Role of adrenal androgens in prostate regression in rats treated with an antiandrogen and an lhrh agonist
Authors:
- 1 January 1986
- journal article
- research article
- Published by Wiley in The Prostate
- Vol. 9 (3) , 227-235
Abstract
Histrelin, a potent luteinizing hormone releasing hormone (LHRH) agonist, and flutamide, an antiandrogen, were administered to intact and adrenalectomized rats to determine the role of adrenal androgens in the additive effects of the two drugs on prostate regression. Each compound, given separately, was effective in decreasing prostate weights in intact rats. When given together, additive effects were demonstrated by even greater atrophy of the prostates. It has previously been proposed that this additive effect may be primarily attributed to the ability of the antiandrogen to block the action of adrenal androgens. However, in adrenalectomized rats, the combination of histrelin and flutamide still produced a greater reduction in prostate weights than did either drug alone, indicating that the role of adrenal androgens in this effect is negligible. This experiment also was repeated with castrate, androgen‐supplemented rats, and the additive effects previously described were not observed. In a final experiment, prostatic atrophy in castrate rats was not enhanced by either adrenalectomy or flutamide treatment. Thus, the additive effects of histrelin and flutamide appear to focus on testicular rather than adrenal androgens.Keywords
This publication has 31 references indexed in Scilit:
- Treatment of prostatic carcinoma with D-Trp-6-LH-RH: Plasma hormone levels after daily subcutaneous injections and periodic administration of delayed-release preparationsThe Prostate, 1985
- Investigation of the combination of the agonist D-Trp-6-LH-RH and the antiandrogen flutamide in the treatment of dunning R-3327H prostate cancer modelThe Prostate, 1985
- Leuprolide versus Diethylstilbestrol for Metastatic Prostate CancerNew England Journal of Medicine, 1984
- Advanced carcinoma of the prostate: treatment with a gonadotrophin releasing hormone agonist.BMJ, 1983
- Combined long-term treatment with an LHRH agonist and a pure antiandrogen blocks androgenic influence in the ratThe Prostate, 1982
- Additive inhibitory effects of treatment with an LHRH agonist and an antiandrogen on androgen-dependent issues in the ratMolecular and Cellular Endocrinology, 1981
- Simultaneous measurements of testosterone and three 5a -reduced androgens in the venous effluent of immature rat testes in situSteroids, 1980
- STEROIDS OF ADRENAL ORIGIN METABOLIZED BY HUMAN PROSTATIC TISSUE BOTH IN VIVO AND IN VITROJournal of Endocrinology, 1974
- Plasma testosterone and androstenedione after orchiectomy in prostatic adenocarcinomaClinical Endocrinology, 1973
- ADRENAL SECRETION OF ANDROGENS AND OESTROGENSJournal of Endocrinology, 1969